ZIPRASIDONE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ziprasidone, and what generic alternatives are available?
Ziprasidone is a drug marketed by Apotex, Aurobindo Pharma, Chartwell Rx, Dr Reddys Labs Inc, Lupin Pharms, Macleods Pharms Ltd, Mylan, Sandoz Inc, Zydus Lifesciences, Gland, MSN, and Steriscience. and is included in twelve NDAs.
The generic ingredient in ZIPRASIDONE is ziprasidone mesylate. There are twenty-three drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the ziprasidone mesylate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ziprasidone
A generic version of ZIPRASIDONE was approved as ziprasidone mesylate by GLAND on December 26th, 2019.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ZIPRASIDONE?
- What are the global sales for ZIPRASIDONE?
- What is Average Wholesale Price for ZIPRASIDONE?
Summary for ZIPRASIDONE
| US Patents: | 0 |
| Applicants: | 12 |
| NDAs: | 12 |
| Drug Prices: | Drug price information for ZIPRASIDONE |
| What excipients (inactive ingredients) are in ZIPRASIDONE? | ZIPRASIDONE excipients list |
| DailyMed Link: | ZIPRASIDONE at DailyMed |
US Patents and Regulatory Information for ZIPRASIDONE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sandoz Inc | ZIPRASIDONE HYDROCHLORIDE | ziprasidone hydrochloride | CAPSULE;ORAL | 077562-004 | Jun 1, 2012 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Mylan | ZIPRASIDONE HYDROCHLORIDE | ziprasidone hydrochloride | CAPSULE;ORAL | 202395-004 | Oct 10, 2013 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Zydus Lifesciences | ZIPRASIDONE HYDROCHLORIDE | ziprasidone hydrochloride | CAPSULE;ORAL | 208988-001 | Aug 22, 2017 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
